Toward more specific and transparent research and development costs: The case of seasonal influenza vaccines

Keyphrases

• Research Costs 100%
• Clinical Development 60%
• Vaccine Candidate 40%
• Development Expenditure 40%
• Research Expenditure 40%
• Drug Research 20%
• Development Time 20%
• Disclosure Incentives 20%
• Investment In Innovation 20%
• Reproducible Research 20%

Immunology and Microbiology

• Influenza 100%
• Vaccine Efficacy 100%
• Preclinical Study 75%
• Influenza Vaccine 25%
• Drug Concentration 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Live Attenuated Influenza Vaccine 100%
• Seasonal Influenza 50%
• Influenza Vaccine 50%